Literature DB >> 8411072

Clinical and molecular studies in fragile X patients with a Prader-Willi-like phenotype.

B B de Vries1, J P Fryns, M G Butler, F Canziani, E Wesby-van Swaay, J O van Hemel, B A Oostra, D J Halley, M F Niermeijer.   

Abstract

A special subphenotype of the fragile X syndrome is reported which is characterised by extreme obesity with a full, round face, small, broad hands/feet, and regional skin hyperpigmentation. It resembles the Prader-Willi syndrome (PWS) and might therefore be named 'Prader-Willi-like'. Unlike the PWS, these PW-like fragile X patients lack the neonatal hypotonia with feeding problems during infancy followed by hyperphagia from toddlerhood. We describe five new fragile X patients and present a clinical update of three previously described patients with the PW-like phenotype. In one family, segregation of either the classical Martin-Bell or the PW-like phenotype was observed and in another family there was repeated transmission of the PW-like phenotype. Previously, one of the patients had been misdiagnosed as having classical PWS, based on clinical findings. Molecular studies of the FMR-1 gene showed the typical full mutations as seen in fragile X syndrome males. Molecular analysis of the 15q11-13 region, which is deleted in the majority of classical PWS patients, did not show any detectable abnormalities. In a group of 26 patients with suspected Prader-Willi syndrome but without detectable molecular abnormalities of chromosome 15, one fragile X patient was found. These clinical and molecular findings illustrate the necessity to perform DNA analysis of the FMR-1 gene in mentally retarded patients presenting with a PW phenotype but without the PWS specific cytogenetic/molecular abnormalities of chromosome 15.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8411072      PMCID: PMC1016534          DOI: 10.1136/jmg.30.9.761

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  21 in total

1.  Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome.

Authors:  I Oberlé; F Rousseau; D Heitz; C Kretz; D Devys; A Hanauer; J Boué; M F Bertheas; J L Mandel
Journal:  Science       Date:  1991-05-24       Impact factor: 47.728

2.  Fragile X genotype characterized by an unstable region of DNA.

Authors:  S Yu; M Pritchard; E Kremer; M Lynch; J Nancarrow; E Baker; K Holman; J C Mulley; S T Warren; D Schlessinger
Journal:  Science       Date:  1991-05-24       Impact factor: 47.728

3.  Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n.

Authors:  E J Kremer; M Pritchard; M Lynch; S Yu; K Holman; E Baker; S T Warren; D Schlessinger; G R Sutherland; R I Richards
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

4.  The nucleotide sequence of chicken smooth muscle myosin light chain two.

Authors:  P J Zavodny; M E Petro; C C Kumar; S H Dailey; H K Lonial; S K Narula; P J Leibowitz
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

5.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

6.  Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.

Authors:  A J Verkerk; M Pieretti; J S Sutcliffe; Y H Fu; D P Kuhl; A Pizzuti; O Reiner; S Richards; M F Victoria; F P Zhang
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

7.  Restriction fragment length polymorphisms within proximal 15q and their use in molecular cytogenetics and the Prader-Willi syndrome.

Authors:  R D Nicholls; J H Knoll; K Glatt; J H Hersh; T D Brewster; J M Graham; D Wurster-Hill; R Wharton; S A Latt
Journal:  Am J Med Genet       Date:  1989-05

8.  A peculiar subphenotype in the fra(X) syndrome: extreme obesity-short stature-stubby hands and feet-diffuse hyperpigmentation. Further evidence of disturbed hypothalamic function in the fra(X) syndrome?

Authors:  J P Fryns; M Haspeslagh; A M Dereymaeker; P Volcke; H Van den Berghe
Journal:  Clin Genet       Date:  1987-12       Impact factor: 4.438

9.  Prader-Willi syndrome: current understanding of cause and diagnosis.

Authors:  M G Butler
Journal:  Am J Med Genet       Date:  1990-03

10.  Population incidence and segregation ratios in the Martin-Bell syndrome.

Authors:  T P Webb; S E Bundey; A I Thake; J Todd
Journal:  Am J Med Genet       Date:  1986 Jan-Feb
View more
  31 in total

1.  DNA methylation and replication: implications for the "deletion hotspot" region of FMR1.

Authors:  K Nichol Edamura; C E Pearson
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

2.  Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome.

Authors:  C A Hoeffer; E Sanchez; R J Hagerman; Y Mu; D V Nguyen; H Wong; A M Whelan; R S Zukin; E Klann; F Tassone
Journal:  Genes Brain Behav       Date:  2012-02-15       Impact factor: 3.449

3.  Parental origin impairment of synaptic functions and behaviors in cytoplasmic FMRP interacting protein 1 (Cyfip1) deficient mice.

Authors:  Leeyup Chung; Xiaoming Wang; Li Zhu; Aaron J Towers; Xinyu Cao; Il Hwan Kim; Yong-hui Jiang
Journal:  Brain Res       Date:  2015-10-17       Impact factor: 3.252

4.  General overgrowth in the fragile X syndrome: variability in the phenotypic expression of the FMR1 gene mutation.

Authors:  B B de Vries; H Robinson; I Stolte-Dijkstra; C V Tjon Pian Gi; P F Dijkstra; J van Doorn; D J Halley; B A Oostra; G Turner; M F Niermeijer
Journal:  J Med Genet       Date:  1995-10       Impact factor: 6.318

5.  The Prader-Willi-like phenotype in fragile X patients: a designation facilitating clinical (and molecular) differential diagnosis.

Authors:  B B De Vries; M F Niermeijer
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

6.  Clinical and molecular studies in fragile X patients with a Prader-Willi-like phenotype.

Authors:  G Gillessen-Kaesbach; B Horsthemke
Journal:  J Med Genet       Date:  1994-03       Impact factor: 6.318

7.  Molecular genetic screening in cytogenetically normal mentally retarded males with manifestations of fragile X syndrome.

Authors:  M G Butler; R Pratesi; C L Vnencak-Jones
Journal:  Am J Med Genet       Date:  1994-07-15

8.  Molecular genetic analysis of mentally retarded males with features of the fragile-X syndrome.

Authors:  M G Butler; R Pratesi; C L Vnencak-Jones
Journal:  J Intellect Disabil Res       Date:  1995-12

Review 9.  The neurobiology of the Prader-Willi phenotype of fragile X syndrome.

Authors:  Zukhrofi Muzar; Reymundo Lozano; Alexander Kolevzon; Randi J Hagerman
Journal:  Intractable Rare Dis Res       Date:  2016-11

10.  Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder.

Authors:  Catalina García-Nonell; Eugenia Rigau Ratera; Susan Harris; David Hessl; Michele Y Ono; Nicole Tartaglia; Emily Marvin; Flora Tassone; Randi J Hagerman
Journal:  Am J Med Genet A       Date:  2008-08-01       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.